论文部分内容阅读
目的:本文结合重症肺炎患者的抗菌疗法,深入研究了抗菌药物降阶梯疗法的临床应用效果。方法:将100例重症肺炎患者随机平均分为两组,分别对两组患者进行抗菌药物降阶梯疗法和常规抗菌疗法两种治疗方式,患者的治疗效果相比具有统计学意义(P<0.05)。结果:通过治疗可知,观察组患者的总治疗有效率为94.00%,对照组为76.00%,观察组患者的治疗效果较优秀(P<0.05)结论:通过临床治疗结果可知,对患者进行全面有效的抗菌药物降阶梯疗法能够有效抑制感染,避免病菌产生耐药性,提高治愈率,是值得临床推广的有效治疗方法。
Objective: In this paper, patients with severe pneumonia antibacterial therapy, in-depth study of anti-bacterial drugs in the clinical application of step-down therapy. Methods: One hundred patients with severe pneumonia were randomly divided into two groups. The two groups were treated with anti-bacterial anti-bacteria therapy and anti-bacterial therapy respectively. The treatment effect was statistically significant (P <0.05) . Results: Through the treatment, the total effective rate was 94.00% in the observation group and 76.00% in the control group, and the treatment group in the observation group was superior (P <0.05). Conclusion: The results of clinical treatment showed that the total effective rate Anti-bacterial anti-bacterial step-down therapy can effectively inhibit the infection, to avoid bacteria resistance and improve the cure rate, is worthy of clinical promotion of effective treatment.